Literature DB >> 15047101

Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO).

Mario A Bianchet1, Margarita Faig, L Mario Amzel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15047101     DOI： 10.1016/S0076-6879(04)82009-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  27 in total

Review 1.  NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.

Authors:  Albena T Dinkova-Kostova; Paul Talalay
Journal:  Arch Biochem Biophys       Date:  2010-03-31       Impact factor: 4.013

2.  Mitochondrial diaphorases as NAD⁺ donors to segments of the citric acid cycle that support substrate-level phosphorylation yielding ATP during respiratory inhibition.

Authors:  Gergely Kiss; Csaba Konrad; Issa Pour-Ghaz; Josef J Mansour; Beáta Németh; Anatoly A Starkov; Vera Adam-Vizi; Christos Chinopoulos
Journal:  FASEB J       Date:  2014-01-03       Impact factor: 5.191

3.  Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis.

Authors:  Abdelkader E Ashour; Adel R Abd-Allah; Hesham M Korashy; Sabry M Attia; Abdelrahman Z Alzahrani; Quaiser Saquib; Saleh A Bakheet; Hala E Abdel-Hamied; Shazia Jamal; Arun K Rishi
Journal:  Mol Cell Biochem       Date:  2014-01-08       Impact factor: 3.396

4.  Interplay of flavin's redox states and protein dynamics: an insight from QM/MM simulations of dihydronicotinamide riboside quinone oxidoreductase 2.

Authors:  Robyn M Mueller; Michael A North; Chee Yang; Sanchita Hati; Sudeep Bhattacharyya
Journal:  J Phys Chem B       Date:  2011-03-16       Impact factor: 2.991

5.  Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems.

Authors:  Chao Yan; Marine Dufour; David Siegel; Philip Reigan; Joe Gomez; Biehuoy Shieh; Christopher J Moody; David Ross
Journal:  Biochemistry       Date:  2011-07-19       Impact factor: 3.162

6.  NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion.

Authors:  Hongfei Zhou; Donna Dehn; Jadwiga K Kepa; David Siegel; Devon E Scott; Wei Tan; David Ross
Journal:  J Pharmacol Exp Ther       Date:  2010-04-08       Impact factor: 4.030

7.  Relationships between metabolic and non-metabolic susceptibility factors in benzene toxicity.

Authors:  David Ross; Hongfei Zhou
Journal:  Chem Biol Interact       Date:  2009-11-24       Impact factor: 5.192

8.  NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.

Authors:  Seema Singh; Muhammad Zahid; Muhammad Saeed; Nilesh W Gaikwad; Jane L Meza; Ercole L Cavalieri; Eleanor G Rogan; Dhrubajyoti Chakravarti
Journal:  J Steroid Biochem Mol Biol       Date:  2009-07-21       Impact factor: 4.292

9.  Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups.

Authors:  Maria F Mendoza; Nicole M Hollabaugh; Suraj U Hettiarachchi; Robin L McCarley
Journal:  Biochemistry       Date:  2012-09-28       Impact factor: 3.162

10.  Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins.

Authors:  Hongbin Dong; Howard G Shertzer; Mary Beth Genter; Frank J Gonzalez; Vasilis Vasiliou; Colin Jefcoate; Daniel W Nebert
Journal:  Biochem Biophys Res Commun       Date:  2013-05-18       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.